Breaking News Instant updates and real-time market news.

DHR

Danaher

$79.03

-0.53 (-0.67%)

17:45
11/28/16
11/28
17:45
11/28/16
17:45

Danaher management to meet with Jefferies

Group dinner to be held in New York on November 28 hosted by Jefferies

  • 28

    Nov

  • 28

    Nov

  • 15

    Dec

DHR Danaher
$79.03

-0.53 (-0.67%)

11/15/16
BOFA
11/15/16
NO CHANGE
Target $93
BOFA
Buy
Danaher added to US 1 List at BofA/Merrill
BofA/Merrill analyst Derik de Bruin added Danaher to the US 1 List saying the company is one of the better positioned Life Sciences sector companies following the US election outcome. The analyst believes Danaher's end markets exposure to Water infrastructure spending, Dental and Product ID businesses, and increased aerospace and defense stand to benefit from the Republican sweep. Further, de Bruin said the Cepheid acquisition is a good strategic fit with its leading molecular diagnostics platform. The analyst reiterates his Buy rating and raised his price target to $93 from $89 on Danaher shares.
11/11/16
COWN
11/11/16
UPGRADE
Target $95
COWN
Outperform
Danaher upgraded to Outperform from Market Perform at Cowen
Cowen analyst Doug Schenkel upgraded Danaher to Outperform and raised his price target to $95 from $85. The analyst believes recent M&A will drive core revenue growth to 5% by 2020, and provides margin expansion opportunities, and recent downward revisions to consensu estimates makes 2016-2018 estimates beatable.
10/12/16
EVER
10/12/16
NO CHANGE
Target $89
EVER
Buy
Danaher acquisition of Phenomenex highly attractive, says Evercore ISI
Evercore ISI analyst Ross Muken is not surprised by Danaher's (DHR) acquisition of Phenomenex saying it is one of the "great consumable assets that remained in Life Science Tools." Muken said the deal terms are "remarkably attractive" and estimates Danaher paid more than $700M for Phenomenex He said revenues are close to $200M, implying an EV/EBITDA multiple in the low to mid-teens, and ROIC north of 10% by year 5, and imply year 1 accretion of 3-5c, and 10-15c by year 5. Muken rates Danaher a Buy with an $89 price target on shares.
09/07/16
BERN
09/07/16
NO CHANGE
BERN
Danaher acquisition should be positive over the mid to long-term, says Bernstein
After Danaher (DHR) agreed to buy Cepheid (CPHD), Bernstein analyst Steven Winoker says that the deal was expensive. However, the analyst says that Cepheid has high recurring revenue, fast growth, and strong synergies with Danaher. Winoker thinks that the deal leaves Danaher well-positioned for growth over the medium to longer term. He keeps a $92 price target and Outperform rating on the stock.

TODAY'S FREE FLY STORIES

SBUX

Starbucks

$57.57

0.03 (0.05%)

19:34
02/22/17
02/22
19:34
02/22/17
19:34
Hot Stocks
Market researcher: Starbucks consumer perception dips after refugee hiring news »

Market researcher YouGov…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

LB

Labarge

$58.13

0.43 (0.75%)

19:33
02/22/17
02/22
19:33
02/22/17
19:33
Hot Stocks
L Brands sees Q1 comps down high-single to low-double digits »

Sees Q1 Go-Forwards comps…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

LB

Labarge

$58.13

0.43 (0.75%)

19:32
02/22/17
02/22
19:32
02/22/17
19:32
Hot Stocks
L Brands sees FY17 comps down low-single digits »

Sees FY17 Go-Forward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

F

Ford

$12.67

-0.02 (-0.16%)

19:30
02/22/17
02/22
19:30
02/22/17
19:30
Conference/Events
Ford to host sales conference call »

Ford U.S. Sales Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

GTLS

Chart Industries

$38.51

-1.21 (-3.05%)

19:27
02/22/17
02/22
19:27
02/22/17
19:27
Hot Stocks
Chart Industries CEO Samuel Thomas named executive chairman »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$273.51

-3.88 (-1.40%)

19:24
02/22/17
02/22
19:24
02/22/17
19:24
Periodicals
SolarCity leased with risky homeowners, has ties to foreclosure cases, NYT says »

In "dozens of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

PRU

Prudential

$110.50

-0.72 (-0.65%)

, WFC

Wells Fargo

$58.36

0.11 (0.19%)

19:16
02/22/17
02/22
19:16
02/22/17
19:16
Hot Stocks
Prudential says could seek compensation from Wells Fargo over MyTerm products »

Prudential (PRU) stated…

PRU

Prudential

$110.50

-0.72 (-0.65%)

WFC

Wells Fargo

$58.36

0.11 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Mar

  • 13

    Apr

  • 06

    Jun

  • 13

    Jul

  • 12

    Oct

  • 15

    Jan

PSA

Public Storage

$226.24

-1.49 (-0.65%)

19:15
02/22/17
02/22
19:15
02/22/17
19:15
Earnings
Public Storage reports Q4 core FFO $2.65, consensus $1.89 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

CS

Credit Suisse

$15.35

-0.13 (-0.84%)

19:10
02/22/17
02/22
19:10
02/22/17
19:10
Periodicals
Credit Suisse probed for potentially aiding tax evasion, WSJ says »

Less than three years…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

LZB

La-Z-Boy

$28.40

-1.05 (-3.57%)

19:09
02/22/17
02/22
19:09
02/22/17
19:09
Downgrade
La-Z-Boy rating change  »

La-Z-Boy downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

CLD

Cloud Peak

$5.68

-0.19 (-3.24%)

19:06
02/22/17
02/22
19:06
02/22/17
19:06
Syndicate
Cloud Peak 13.5M share Spot Secondary priced at $5.10 »

Credit Suisse, JPMorgan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

SNAP

Snap Inc

18:47
02/22/17
02/22
18:47
02/22/17
18:47
Periodicals
Snap Inc nears $200M ad deal, NY Post says »

Snap Inc is close to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

SBLK

Star Bulk Carriers

$9.59

0.29 (3.12%)

18:40
02/22/17
02/22
18:40
02/22/17
18:40
Earnings
Star Bulk Carriers reports Q4 EPS (29c), consensus (28c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 22

    Mar

C

Citi

$60.62

0.07 (0.12%)

18:35
02/22/17
02/22
18:35
02/22/17
18:35
Periodicals
Citi forms regulatory affairs team in D.C., Bloomberg says »

Citi is forming a global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

PRAH

PRA Health

$59.98

-0.71 (-1.17%)

18:34
02/22/17
02/22
18:34
02/22/17
18:34
Earnings
PRA Health sees FY17 EPS $3.08-$3.18, consensus $2.96 »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

FGL

Fidelity & Guaranty Life

$26.30

-0.1 (-0.38%)

, ATH

Athene Holding

$51.45

0.38 (0.74%)

18:32
02/22/17
02/22
18:32
02/22/17
18:32
Periodicals
Fidelity & Guaranty Life revives sale process, Insurance Insider says »

Fidelity & Guaranty…

FGL

Fidelity & Guaranty Life

$26.30

-0.1 (-0.38%)

ATH

Athene Holding

$51.45

0.38 (0.74%)

APO

Apollo Global

$22.25

0.05 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

PRAH

PRA Health

$59.98

-0.71 (-1.17%)

18:31
02/22/17
02/22
18:31
02/22/17
18:31
Earnings
PRA Health sees Q1 EPS 57c-62c, consensus 67c »

Sees Q1 service revenues…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

NBR

Nabors Industries

$15.44

0.01 (0.06%)

18:30
02/22/17
02/22
18:30
02/22/17
18:30
Earnings
Nabors Industries reports Q4 EPS ($1.17) with items »

Q4 EPS includes 87c in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

AXGN

AxoGen

$10.50

-0.1 (-0.94%)

18:28
02/22/17
02/22
18:28
02/22/17
18:28
Earnings
AxoGen reiterates FY17 revenue growth view of at least 40% »

Management reiterates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 14

    Mar

  • 21

    Mar

AXGN

AxoGen

$10.50

-0.1 (-0.94%)

18:26
02/22/17
02/22
18:26
02/22/17
18:26
Earnings
AxoGen reports Q4 EPS (10c), consensus (9c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 14

    Mar

  • 21

    Mar

GEN

Genesis Healthcare

$3.83

-0.05 (-1.29%)

18:26
02/22/17
02/22
18:26
02/22/17
18:26
Earnings
Genesis Healthcare sees FY17 revenue $5.4B-$5.6B, consensus $5.64B »

Sees FY17 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

URRE

Uranium Resources

$1.91

-0.06 (-3.05%)

18:25
02/22/17
02/22
18:25
02/22/17
18:25
Hot Stocks
Uranium Resources reports favorable lithium concentrations at Columbus Basin »

Uranium Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GEN

Genesis Healthcare

$3.83

-0.05 (-1.29%)

18:24
02/22/17
02/22
18:24
02/22/17
18:24
Earnings
Genesis Healthcare reports Q4 revenue $1.4B, consensus $1.4B »

Reports Q4 net income…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

MCRI

Monarch Casino

$23.98

-0.22 (-0.91%)

18:22
02/22/17
02/22
18:22
02/22/17
18:22
Earnings
Monarch Casino reports Q4 EPS 36c, consensus 33c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBMX

CombiMatrix

$4.10

-0.1 (-2.38%)

, UCTT

Ultra Clean

$12.58

0.2 (1.62%)

18:22
02/22/17
02/22
18:22
02/22/17
18:22
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

CBMX

CombiMatrix

$4.10

-0.1 (-2.38%)

UCTT

Ultra Clean

$12.58

0.2 (1.62%)

SQ

Square

$15.04

0.41 (2.80%)

CTRP

Ctrip.com

$47.59

0.53 (1.13%)

TSLA

Tesla

$273.51

-3.88 (-1.40%)

BLCM

Bellicum Pharmaceuticals

$12.79

-0.6 (-4.48%)

LB

Labarge

$58.13

0.43 (0.75%)

TSRA

Tessera

$44.65

-0.2 (-0.45%)

ARRS

ARRIS

$30.70

0.75 (2.50%)

JACK

Jack in the Box

$103.60

-3.77 (-3.51%)

SAM

Boston Beer

$166.85

-1.9 (-1.13%)

ELGX

Endologix

$6.53

0.04 (0.62%)

CSGP

CoStar Group

$210.02

-1.35 (-0.64%)

FMI

Foundation Medicine

$23.85

-0.6 (-2.45%)

AXGN

AxoGen

$10.50

-0.1 (-0.94%)

CLD

Cloud Peak

$5.68

-0.19 (-3.24%)

NGD

New Gold

$3.04

-0.08 (-2.56%)

NVDA

NVIDIA

$110.76

-0.31 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 28

    Feb

  • 05

    Mar

  • 14

    Mar

  • 16

    Mar

  • 16

    Mar

  • 21

    Mar

  • 21

    Mar

  • 22

    Mar

  • 22

    Mar

  • 23

    Mar

  • 23

    Mar

  • 27

    Mar

  • 27

    Mar

  • 28

    Mar

  • 23

    Feb

  • 23

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.